Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence

A proportion of patients with interstitial lung diseases (ILDs) are at risk of developing a progressive-fibrosing phenotype, which is associated with a deterioration in lung function and early mortality. In addition to idiopathic pulmonary fibrosis (IPF), fibrosing ILDs that may present a progressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Richeldi, Luca, Varone, Francesco, Bergna, Miguel, de Andrade, Joao, Falk, Jeremy, Hallowell, Robert, Jouneau, Stéphane, Kondoh, Yasuhiro, Morrow, Lee, Randerath, Winfried, Strek, Mary, Tabaj, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488647/
https://www.ncbi.nlm.nih.gov/pubmed/30578333
http://dx.doi.org/10.1183/16000617.0074-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488647/
https://www.ncbi.nlm.nih.gov/pubmed/30578333
http://dx.doi.org/10.1183/16000617.0074-2018

Ejemplares similares